This compound is a difluorinated, bis-amide derivative containing two ether-linked pyridine rings. It is primarily used as a reference standard for identifying and quantifying the regorafenib impurity during pharmaceutical manufacturing and quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2438857-80-6
5-Methyl-2'-methoxyethoxycytosine
pharmaceutical intermediate
4,6-Dibromoisophthalonitrile
pharmaceutical intermediate
3-morpholino-1-(3-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
pharmaceutical intermediate
N-[5-(4-Bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4- pyrimidinyl]-N'-propylsulfamide
pharmaceutical intermediate
N,N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
research compound
Methyl 4-(4-(3-(4-((2-(Methylcarbamoyl)pyridin-4-yl)oxy)phenyl)ureido)phenoxy)picolinate
pharmaceutical intermediate
4-[3-fluoro-4-[[2-fluoro-4-[[2-(methylcarbamoyl)-4-pyridinyl]oxy]phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
FVLPWAWFQLLRPG-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=C(C=C(C=C3)OC4=CC(=NC=C4)C(=O)NC)F)F